9
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Inflammatory and fibrotic mediator release by alveolar macrophages from coal miners

, , &
Pages 9-21 | Received 06 Feb 1995, Accepted 04 Apr 1995, Published online: 19 Oct 2009
 

Abstract

Eicosanoids and cytokines produced by alveolar macrophages (AM) are key mediators of pulmonary inflammation and fibrosis. In order to determine if eicosanoid production and cytokine production are altered in AM obtained from coal miners, we compared production of prostaglandin E2 (PGE2), thromboxane A2 (TXA2), leukotriene B4 (LTB4), interleukin‐1 beta (IL‐1β), and tumor necrosis factor alpha (TNFα) by cultured AM from normal human subjects and coal miners. The recovery of AM from miners’ lungs by bronchoalveolar lavage was significantly greater than that from control subjects. Mean eicosanoid and cytokine production by AM from active miners was also increased compared to AM from control subjects, but this increase was not statistically significant. AM from control subjects produced significantly more TXA2 and TNFα when exposed to lipopolysaccharide than did AM from miners. The cyclooxygenase inhibitor suprofen reduced PGE2 and TXA2 production and TNFα release but had no effect on LTB4 production or IL‐1β release by miners’ AM. The lipoxygenase inhibitor nordihydroguaiaretic acid attenuated TNFα release, as well as that of LTB4, but had no effect on IL‐1β release. Inhibition of thromboxane synthase by UK 38,485 also reduced TNFα release by active miners’ AM but had no effect on PGE2, LTB4 production, or IL‐1β release. The results of these studies suggest that occupational inhalation of coal dust may increase total lung eicosanoid and cytokine levels and reduce the reactivity of AM to bacterial endotoxin. Furthermore, coal dust‐induced changes in both eicosanoid and cytokine release may be subject to pharmacological modulation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.